Evidence map›Paper›PMID 28285461›Full record

ArticleInflammation2017

Effects of SDF-1/CXCR4 on Acute Lung Injury Induced by Cardiopulmonary Bypass.

Hai Shi, Rujian Lu, Shuo Wang, Honglin Chen, Fei Wang, Kun Liu

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Development of CXCR4 modulators based on the lead compound RB-108.European journal of medicinal chemistry · 2019
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Hai ShiDepartment of Cardiothoracic Surgery, The Third People's Hospital of Nantong, Nantong, Jiangsu, 226001, People's Republic of China.
Rujian LuDepartment of Cardiothoracic Surgery, The Third People's Hospital of Nantong, Nantong, Jiangsu, 226001, People's Republic of China.
Shuo WangNantong University, Nantong, Jiangsu, 226001, People's Republic of China.
Honglin ChenNantong University, Nantong, Jiangsu, 226001, People's Republic of China.
Fei WangDepartment of Cardiothoracic Surgery, Affiliated Hospital of Nantong University, Nantong, 226001, People's Republic of China. ntfywangfei@sina.com.
Kun LiuDepartment of Cardiothoracic Surgery, Affiliated Hospital of Nantong University, Nantong, 226001, People's Republic of China. ntliukun@163.com.
Nantong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute lung injury (ALI) is one of the most important complications after cardiopulmonary bypass (CPB) and the complex pathophysiology remains to be resolved incomplete. SDF-1/CXCR4 chemokine axis can chemotactically accumulate inflammatory cell to local tissue and regulate the release of inflammatory factors, and SDF-1 has a strong chemotaxis effect on neutrophils with CXCR4. Since CPB animal model was difficult to establish, there was still no report about the effect of SDF-1/CXCR4 on neutrophil chemotaxis in ALI after CPB. Here, a stable CPB rat model was constructed to clarify the role of SDF-1/CXCR4 axis in the CPB-induced ALI. Real-time quantitative PCR (RT-qPCR), Western blot analysis, and enzyme-linked immunosorbent assay (ELISA) were used to detect the changes of SDF-1 and CXCR4 in lung tissues, blood, bronchoalveolar lavage (BALF), and/or isolated neutrophils. SDF-1/CXCR4 was increased after CPB, both of that were increased in blood; CXCR4 was increased in neutrophils; SDF-1/CXCR4 was also increased in BALF of CPB model. Results indicated that SDF-1/CXCR4 axis played a key role in the process of early ALI after CPB, also showed that lung injury was significantly reduce after blocking SDF-1/CXCR4 axis, suggest that CXCR4 might be a new target for ALI treatment.

Indexed as

Acute Lung InjuryAnimalsCardiopulmonary BypassChemokine CXCL12ChemotaxisMaleNeutrophilsRatsRats, Sprague-DawleyReceptors, CXCR4Chemokine CXCL12CXCL12 protein, ratCxcr4 protein, ratReceptors, CXCR4cardiopulmonary bypasschemokineCXCR4lung injurySDF-1

Identifiers

PMID28285461
OpenAlexW2592204251

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.